podophyllotoxin has been researched along with Carcinoma, Small Cell in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 97 (90.65) | 18.7374 |
1990's | 10 (9.35) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feringa, BL; Jansen, JF; Kellogg, RM; Konings, AW; Middel, O; Pras, N; van Oeveren, A; van Uden, W; Woerdenbag, HJ | 1 |
Hamel, E; Kuo, SC; Lednicer, D; Lee, KH; Li, L; Lin, CM; Wang, HK; Wu, TS | 1 |
Haaxma-Reiche, H; Meinesz, AF; Mulder, NH; Postmus, PE; Sleijfer, DT; Vencken, LM | 1 |
Antman, K; Canellos, G; Karp, G; Pomfret, E; Skarin, A | 1 |
Kinameri, K; Kurita, Y; Yokoyama, A | 1 |
Bender, HW; Foster, JM; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Prager, RL; Wolff, SN | 1 |
Caldwell, RD; Case, LD; Harding, RW; Hopkins, JO; Jackson, DV; Muss, HB; Richards, F; Slatkoff, ML; White, DR; Zekan, PJ | 1 |
De Vries, EG; Meinesz, AF; Mulder, NH; Orie, JL; Postmus, PE; Sleijfer, DT; Van der Geest, S; Vriesendorp, R | 1 |
Bork, E; Dombernowsky, P; Hansen, HH; Osterlind, K; Pedersen, AG | 1 |
Bjelić, R; Dangubić, V; Mrda, V; Perunović, O; Popvić, D; Sikimić, S; Spasić, D; Vukov, N | 1 |
Bagwell, S; Broder, LE; Charyulu, KN; Ng, A; Selawry, OS | 1 |
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Sonntag, RW | 1 |
Kessinger, A; Lemon, HM; Tempero, M | 1 |
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R; Ryssel, HJ; Sonntag, RW | 1 |
Kennedy, BJ; Raghavan, D; Vogelzang, NJ | 1 |
Bunn, PA; Cohen, MH; Hawley, RJ; Ihde, DC; Matthews, MJ; Minna, JD; Smith, MT; Thant, M; West, W | 1 |
Calciati, A; Conte, PF; Giaccone, G; Musella, R | 1 |
Dally, MB; Geddes, DM; Harper, PG; Smyth, JF; Souhami, RL; Spiro, SG | 1 |
Cortés Funes, H; Dominguez, P; Lanzos, E; Mendez, M; Mendiola, C; Torrubia, AP | 1 |
Aisner, J; VanEcho, DA; Wesley, M; Whitacre, M; Wiernik, PH | 1 |
Gomez, RG; Madrigal, PA; Manga, GP; Palomero, I | 1 |
Klastersky, J; Longeval, E; Nicaise, C; Stryckmans, P | 1 |
Bowden, GT; Giever, RJ; Heusinkveld, RS; Manning, MR | 1 |
Bitran, JD; DeMeester, TR; Golomb, HM; Hoffman, PC; Newman, SB; Raghavan, V | 1 |
Bremer, K; Krischke, W; Niederle, N; Schmidt, CG; Seeber, S | 1 |
Ammon, J; Essers, U; Knechten, H; Seelis, R | 1 |
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R | 1 |
Natale, RB; Wittes, RE | 1 |
Havemann, K | 1 |
Agusti, A; Estape, J; Milla, A; Rozman, C; Sanchez-Lloret, J; Santabarbara, P | 1 |
Cooper, MR; Jackson, DV; Muss, HB; Pope, EK; Richards, F; Spurr, CL; Stuart, JJ; Wells, HB; White, DR | 1 |
Asbury, RF; Bennett, JM; Rubins, J | 1 |
Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Wolff, SN | 1 |
Hansen, HH; Pedersen, AG | 1 |
Deboer, G; Dill, J; Evans, WK; Feld, R; Osoba, D; Shepherd, FA | 1 |
Davis, SL; Goodman, GE; Manning, MM; McMahon, LJ; Miller, TP | 1 |
Haaxma-Reiche, H; Holthuis, JJ; Mulder, NH; Postmus, PE; Sleijfer, DT; Sluiter, HJ; van Oort, WJ; Vencken, LM | 1 |
Araya, Y; Dosaka, H; Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Onodera, S; Shimizu, T; Takaoka, K | 1 |
Edmundson, JM; Shiu, W; Steward, WP; Thatcher, N; Wilkinson, PM | 1 |
Díaz Pérez, MA; García de Paredes, ML; González Larriba, JL; Montero García, JM; Ordóñez Gallego, A; Zamora, P | 1 |
Gregor, A; Smyth, JF | 1 |
Jensen, PB | 1 |
Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
Cordier, JF; Trillet-Lenoir, V | 1 |
Bestry, I; Dańczak-Ginalska, Z; Rowińska-Zakrzewska, E; Starzyńska, T; Wiatr, E; Zych, J | 1 |
Campling, BG; Jain, N; Lam, YM; Pym, J | 1 |
Schacter, L | 1 |
Goto, T; Kozuru, M; Kumagawa, M; Muta, K; Suehiro, Y; Uike, N | 1 |
Beckmann, C; Flury, R; Frei, P; Holdener, E; Jungi, WF; Senn, HJ | 1 |
Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, F | 1 |
Weiss, RB | 1 |
Ferguson, A; Hewitson, R; Levin, W; Sealy, R; Tucker, RD; Van Wyk, C | 1 |
Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
Fontana, JA | 1 |
Bunn, PA; Ihde, DC; Radice, PA | 1 |
Coldman, AJ; Klasa, RJ; Murray, N | 1 |
Cellerino, R; Di Furia, L; Gramazio, A; Guidi, F; Menichetti, E; Tummarello, D | 1 |
Barnes, S; Bartholomew, MJ; Dixon, R; Gordon, R; Harvey, HA; Lipton, A; Valdivia, D; Walker, B; Warzawski, N; White-Hershey, D | 1 |
Roed, H; Vindeløv, LL | 1 |
McVie, G; Muggia, FM | 1 |
Bye, P; Crombie, C; Fox, RM; Green, D; Peretz, G; Raghavan, D; Stuart-Harris, R; Teriana, N; Tiver, K; Young, I | 1 |
D'Incalci, M; Figoli, F; Lestuzzi, C; Monfardini, S; Sorio, R; Tirelli, U; Urso, R; Zanette, ML | 1 |
Arkles, B; Cosolo, W; Morstyn, G; Zalcberg, JR; Zimet, AS | 1 |
Bonardi, GM; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
Bearden, JD; Caldwell, RD; Case, LD; Cooper, MR; Jackson, DV; Muss, HB; Nelson, EC; Powell, BL; Richards, F; Zekan, PJ | 1 |
Abad-Esteve, A; Fernández-Marcial, C; Moreno, I; Ribas Mundó, M; Rosell, R; Roselló, M | 1 |
Fujii, M; Moriwaki, S; Takiyama, W | 1 |
Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
Brunner, KW; Cerny, T; Joss, RA; Pedrazzini, A | 1 |
Berendsen, HH; Haaxma-Reiche, H; Postmus, PE | 1 |
Anderson, PN; Baker, LH; Comis, RL; Daniels, JR; Einhorn, LH; Harvey, HA; Issell, BF; Lanzotti, VA; Lawson, RD; Wampler, GL | 1 |
Greco, FA; Grosh, WW; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
Klastersky, J; Sculier, JP; Stryckmans, P | 1 |
Abratt, RP; Levin, W | 1 |
Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ; Wittes, RE | 1 |
Ahmedzai, S; Banham, S; Burnett, A; Cunningham, D; Dorward, A; Hutcheon, A; Kaye, S; Lucie, N; Soukop, M | 1 |
Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
Bateman, NT; Bellamy, D; Calman, FM; Costello, J; Farebrother, M; Rubens, RD; Slevin, ML; Timothy, AR | 1 |
Tanneberger, S | 1 |
Finkel, H; Grapski, RT; Krikorian, JG; Lopez, JA; Mann, J; Nassif, E; Vannicola, P | 1 |
Adelstein, DJ; Hines, JD | 1 |
Danigel, H; Dellbrügge, J; Jungclas, H; Pflüger, KH; Schmidt, L | 1 |
Chikata, E; Hara, K; Ito, F; Kado, M; Kanda, T; Matsui, Y; Nakayama, M; Ohshima, S; Sakai, S; Shimokata, K | 1 |
Harvey, VJ; Joel, SP; Johnston, A; Slevin, ML; Wrigley, PF | 2 |
Kimura, K; Niitani, H | 1 |
Ahmedzai, S; Banham, SW; Cunningham, D; Dorward, A; Hutcheon, AH; Kaye, SB; Soukop, M; Stack, BR; Stevenson, RD; Tansey, P | 1 |
Dang, P; Deboer, G; Evans, WK; Feld, R; Osoba, D; Shepherd, FA | 1 |
Furuse, K | 1 |
Harvey, VJ; Joel, SP; Johnston, A; Slevin, ML; Smythe, MM; Wrigley, PF | 1 |
Hara, K; Kado, M; Kanda, T; Matsui, Y; Oshima, S; Shima, K; Shimokata, K; Takenaka, S | 1 |
Bakaert, AB; De Broe, ME; Holthuis, JJ; Van de Vyver, FL; van Oort, WJ; Verleun, H | 1 |
Livingston, RB | 1 |
Bork, E; Dombernowsky, P; Hansen, HH; Hansen, M; Hansen, SW; Pedersen, AG | 1 |
Hiraga, Y; Ito, T; Konno, K; Nagahama, F; Nakabayashi, T; Nakai, Y; Oizumi, K; Sato, M; Takebe, K; Tamura, M | 1 |
Kinameri, K; Kurita, Y; Matsuura, N; Sano, K; Yokoyama, A | 1 |
Hara, K; Ikebe, A; Ishizaki, T; Iwasaki, H; Kanda, T; Koteda, T; Nakano, M; Oka, M; Okuno, K; Tsutsumi, T | 1 |
Birch, R; Greco, FA; Sarma, P; Wolff, SN | 1 |
Brattain, MG; Long, BH; Musial, ST | 1 |
Bentley, DP; Littlewood, TJ; Smith, AP | 1 |
Eguchi, K; Morinaga, S; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suga, J; Tamura, T | 1 |
Cummings, J; Cunningham, D; Forrest, GJ; McTaggart, L; Soukop, M; Stuart, JF | 1 |
Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Klapsing, J; Manke, HG; Schroeder, M; Viktor, N | 1 |
Coles, DT; Creagan, ET; Eagan, RT; Frytak, S; Jett, JL; Lee, RE; Richardson, RL | 1 |
Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
12 review(s) available for podophyllotoxin and Carcinoma, Small Cell
Article | Year |
---|---|
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
Topics: Bronchial Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Small Cell; Cell Division; Choriocarcinoma; Etoposide; Female; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Male; Ovarian Neoplasms; Podophyllotoxin; Pregnancy; Testicular Neoplasms; Uterine Neoplasms | 1981 |
Etoposide (VP-16) in the treatment of lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Time Factors | 1983 |
Management of small cell cancer: intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1984 |
Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Humans; Lung Neoplasms; Phenotype; Podophyllotoxin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
[Origin of small cell lung cancers].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Neoplasm Metastasis; Platinum; Podophyllotoxin | 1993 |
Etoposide phosphate: what, why, where, and how?
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Clinical Trials as Topic; Etoposide; Humans; Lung Neoplasms; Organophosphorus Compounds; Podophyllotoxin | 1996 |
Small-cell carcinoma of the lung: therapeutic management.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Brain; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Lung Neoplasms; Methotrexate; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Vinblastine; Vincristine | 1978 |
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Meta-Analysis as Topic; Podophyllotoxin; Vincristine | 1991 |
A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Retrospective Studies; Teniposide | 1989 |
Can human small-cell lung cancer cell lines be applied for optimizing chemotherapy?
Topics: Animals; Carcinoma, Small Cell; Colony-Forming Units Assay; DNA, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitrosourea Compounds; Platinum; Podophyllotoxin; Tumor Cells, Cultured | 1989 |
Etoposide (VP-16-213). Current status of an active anticancer drug.
Topics: Animals; Carcinoma, Small Cell; Clinical Trials as Topic; DNA; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Podophyllotoxin; Testicular Neoplasms; Tissue Distribution | 1985 |
Current chemotherapy of small cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1986 |
14 trial(s) available for podophyllotoxin and Carcinoma, Small Cell
Article | Year |
---|---|
VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Vincristine | 1984 |
A controlled clinical trial testing two potentially non-cross-resistant chemotherapeutic regimens in small-cell carcinoma of the lung.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Prognosis; Time Factors | 1981 |
VP-16-213 (etoposide): the mandrake root from Issyk-Kul.
Topics: Animals; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dysgerminoma; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Mice; Podophyllotoxin | 1982 |
Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1982 |
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nervous System Diseases; Podophyllotoxin; Random Allocation; Vincristine | 1983 |
[The role of radiotherapy in combined treatment of limited small cell lung cancer in relation to results of induction chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Remission Induction; Survival Rate; Vincristine | 1995 |
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide | 1979 |
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Meta-Analysis as Topic; Podophyllotoxin; Vincristine | 1991 |
Chemotherapy plus RA233 in the treatment of oat cell lung cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mopidamol; Podophyllotoxin; Prospective Studies; Pyrimidines; Random Allocation; Vincristine | 1989 |
Improvement of long-term survival in extensive small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prognosis; Random Allocation; Vincristine | 1988 |
Etoposide (VP-16-213). Current status of an active anticancer drug.
Topics: Animals; Carcinoma, Small Cell; Clinical Trials as Topic; DNA; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Male; Mice; Podophyllotoxin; Testicular Neoplasms; Tissue Distribution | 1985 |
Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Topics: Carcinoma, Small Cell; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation | 1986 |
Two randomized trials for alternating polychemotherapy of small cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Random Allocation; Sex Factors; Smoking; Time Factors; Vincristine; Vindesine | 1986 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
83 other study(ies) available for podophyllotoxin and Carcinoma, Small Cell
Article | Year |
---|---|
Synthesis and cytotoxicity of novel lignans.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Humans; Lignans; Lung Neoplasms; Tumor Cells, Cultured | 1995 |
Antitumor agents. 150. 2',3',4',5',5,6,7-substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Small Cell; Cattle; Cell Division; Central Nervous System Neoplasms; Colonic Neoplasms; Female; Humans; Leukemia; Lung Neoplasms; Molecular Structure; Polymers; Quinolones; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 1994 |
Remission of brain metastases from small-cell lung cancer after high-dose chemotherapy.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1984 |
Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
Topics: Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Podophyllotoxin | 1984 |
[Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1984 |
The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prospective Studies; Vincristine | 1984 |
Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin | 1984 |
Phase II study of teniposide in small cell carcinoma of the lung.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1984 |
[Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Podophyllotoxin; Vincristine | 1983 |
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1981 |
VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1981 |
Possible enhancement of vincristine neuropathy by VP-16.
Topics: Aged; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Electrophysiology; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Muscles; Nervous System Diseases; Peripheral Nerves; Podophyllotoxin; Vincristine | 1982 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed | 1981 |
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.
Topics: Bronchial Neoplasms; Carcinoma, Small Cell; Drug Resistance; Drug Therapy, Combination; Etoposide; Humans; Podophyllotoxin | 1982 |
Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Time Factors | 1982 |
VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1982 |
Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
Topics: Adult; Aged; Agranulocytosis; Bone Marrow Transplantation; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukocyte Count; Male; Middle Aged; Pilot Projects; Podophyllotoxin; Thrombocytopenia | 1982 |
Enhanced radiation reaction following combination chemotherapy for small cell carcinoma of the lung, possibly secondary to VP16-213.
Topics: Aged; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Radiotherapy; Vincristine | 1982 |
VP16-213 in combined modality treatment of small cell carcinoma of the lung.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Nausea; Neoplasm Staging; Podophyllotoxin | 1982 |
Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Therapy, Combination; Etoposide; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1982 |
Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin; Vincristine | 1982 |
Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1982 |
Combination cis-platinum and etoposide in small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1982 |
Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Podophyllotoxin; Vinblastine; Vincristine; Vindesine | 1982 |
VP-16 plus cyclophosphamide in the treatment of advanced lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Probability | 1983 |
Etoposide in small cell lung cancer resistant to prior chemotherapy.
Topics: Carcinoma, Small Cell; Drug Resistance; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1983 |
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung.
Topics: Adult; Aged; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1983 |
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia; Time Factors | 1984 |
Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leukopenia; Lung Neoplasms; Nausea; Nervous System Diseases; Podophyllotoxin; Vincristine | 1983 |
Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Humans; Injections, Intravenous; Lung Neoplasms; Middle Aged; Podophyllotoxin; Tomography, X-Ray Computed | 1984 |
Etoposide (VP 16-213; VePesid).
Topics: Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Podophyllotoxin; Testicular Neoplasms | 1984 |
[Effects of oral etoposide in small cell carcinoma of the lung].
Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Nausea; Podophyllotoxin; Thrombocytopenia | 1984 |
Etoposide infusions for treatment of metastatic lung cancer.
Topics: Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Etoposide; Follow-Up Studies; Humans; Infusions, Parenteral; Kinetics; Lung Neoplasms; Neoplasm Metastasis; Podophyllotoxin | 1984 |
[Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1984 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cadmium; Cadmium Chloride; Carcinoma, Small Cell; Cell Line; Chlorides; Cisplatin; Cross Reactions; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Lung Neoplasms; Metallothionein; Platinum Compounds; Podophyllotoxin; Teniposide; Tumor Cells, Cultured; Vinca Alkaloids | 1996 |
Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chromosomes, Human, Pair 11; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Myeloid-Lymphoid Leukemia Protein; Podophyllotoxin; Proto-Oncogenes; Transcription Factors; Translocation, Genetic; Vincristine; Zinc Fingers | 1997 |
Epipodophyllotoxin (VP 16-213) in the treatmetn of diffuse histiocytic lymphoma.
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Prospective Studies; Remission, Spontaneous | 1975 |
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Remission, Spontaneous | 1975 |
Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside).
Topics: Administration, Oral; Aged; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Solutions | 1977 |
Chemotherapy of small cell carcinoma of the lung with V.P. 16-213.
Topics: Bone Marrow; Carcinoma, Small Cell; Disability Evaluation; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Time Factors | 1978 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
Radiation recall associated with VP-16-213 therapy.
Topics: Carcinoma, Small Cell; Erythema; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin; Radiation Injuries; Radiation-Sensitizing Agents; Time Factors | 1979 |
Treatment strategies in relation to drug action.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; DNA Topoisomerases, Type II; Etoposide; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Podophyllotoxin; Teniposide | 1987 |
Chemotherapy for small cell lung cancer: induction and reinduction with VOCA.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Vincristine | 1987 |
Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Pericardium; Podophyllotoxin; Teniposide | 1987 |
Flare responses in small cell carcinoma of the lung.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Podophyllotoxin; Radionuclide Imaging | 1988 |
Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1988 |
[VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Time Factors; Vincristine | 1988 |
Small cell carcinoma of the esophagus: report of a case treated with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Humans; Male; Middle Aged; Podophyllotoxin; Vincristine | 1988 |
Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Topics: Aged; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prognosis; Teniposide | 1988 |
Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Podophyllotoxins for brain metastases of small cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Topics: Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Multi-Institutional Systems; Nausea; Podophyllotoxin; Vomiting | 1985 |
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Thrombocytopenia; Vincristine | 1985 |
Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Podophyllotoxin | 1985 |
Probable cure of small cell carcinoma of the lung by etoposide.
Topics: Carcinoma, Small Cell; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Radiography; Smoking | 1985 |
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group.
Topics: Carcinoma, Small Cell; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Verapamil | 1985 |
High-dose etoposide (VP-16) in small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin | 1985 |
Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin; Vincristine | 1985 |
[Antineoplastic chemotherapy for bronchial carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Vinblastine; Vincristine; Vindesine | 1985 |
Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Platelet Count; Podophyllotoxin | 1985 |
Bone marrow morphologic changes after combination chemotherapy including VP-16.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Erythrocytes; Etoposide; Female; Hematopoiesis; Humans; Lung Neoplasms; Male; Mitosis; Podophyllotoxin; Vincristine | 1985 |
Drug monitoring of etoposide (VP16-213). I. A combined method of liquid chromatography and mass spectrometry.
Topics: Californium; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Computers; Etoposide; Half-Life; Humans; Kinetics; Lung Neoplasms; Mass Spectrometry; Podophyllotoxin | 1985 |
[A phase II study of oral VP-16 in primary lung cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Capsules; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1985 |
The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Carcinoma, Small Cell; Drug Interactions; Etoposide; Food; Humans; Kinetics; Lung Neoplasms; Podophyllotoxin | 1985 |
[A phase II study of NK171 (etoposide)].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1985 |
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Podophyllotoxin | 1985 |
VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Podophyllotoxin; Thrombocytopenia; Time Factors | 1985 |
[A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Fatigue; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1985 |
Variable bioavailability following repeated oral doses of etoposide.
Topics: Adult; Biological Availability; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Humans; Kinetics; Lung Neoplasms; Mesothelioma; Podophyllotoxin; Time Factors | 1985 |
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1986 |
Pharmacokinetic evaluation of increasing dosages of etoposide in a chronic hemodialysis patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Kidney Failure, Chronic; Kinetics; Lung Neoplasms; Male; Mathematics; Middle Aged; Podophyllotoxin; Renal Dialysis | 1985 |
The effect of dose on the bioavailability of oral etoposide.
Topics: Administration, Oral; Adult; Biological Availability; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Etoposide; Half-Life; Humans; Kinetics; Mesothelioma; Podophyllotoxin; Random Allocation | 1986 |
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Topics: Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1986 |
[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Topics: Adult; Aged; Alopecia; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin | 1986 |
[Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1986 |
[Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
Topics: Administration, Oral; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1986 |
DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Topics: Adenocarcinoma; Adenosine Triphosphate; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cells, Cultured; DNA; DNA, Single-Stranded; Drug Resistance; Etoposide; Humans; Intercalating Agents; Lung Neoplasms; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1986 |
High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer--a negative report.
Topics: Bone Marrow Diseases; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mouth Mucosa; Podophyllotoxin; Stomatitis; Transplantation, Autologous | 1986 |
A case of small cell lung cancer successfully treated with VM26.
Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Male; Podophyllotoxin; Teniposide | 1986 |
Etoposide: a pharmacokinetic profile including an assessment of bioavailability.
Topics: Administration, Oral; Biological Availability; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Hodgkin Disease; Humans; Injections, Intravenous; Kinetics; Lung Neoplasms; Lymphoma; Male; Neoplasms; Podophyllotoxin | 1986 |
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Vincristine | 1987 |